A group of shareholders owning 10 per cent of Nasdaq-listed Bray medical firm Trinity Biotech are to spend almost $170,000 (€130,000) to overcome a loophole in Irish company law that has prevented them from demanding an egm aimed at ousting the company’s board.
The shareholder group, headed by Kansas-based investor Tom Reidy, initiated its action earlier this month after the Trinity board, led by chairman and chief executive Ronan O’Caoimh, ruled a previous attempt to...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team